Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 8 (3), 253-61

Modular Flexibility of Dystrophin: Implications for Gene Therapy of Duchenne Muscular Dystrophy

Affiliations

Modular Flexibility of Dystrophin: Implications for Gene Therapy of Duchenne Muscular Dystrophy

Scott Q Harper et al. Nat Med.

Abstract

Attempts to develop gene therapy for Duchenne muscular dystrophy (DMD) have been complicated by the enormous size of the dystrophin gene. We have performed a detailed functional analysis of dystrophin structural domains and show that multiple regions of the protein can be deleted in various combinations to generate highly functional mini- and micro-dystrophins. Studies in transgenic mdx mice, a model for DMD, reveal that a wide variety of functional characteristics of dystrophy are prevented by some of these truncated dystrophins. Muscles expressing the smallest dystrophins are fully protected against damage caused by muscle activity and are not morphologically different from normal muscle. Moreover, injection of adeno-associated viruses carrying micro-dystrophins into dystrophic muscles of immunocompetent mdx mice results in a striking reversal of histopathological features of this disease. These results demonstrate that the dystrophic pathology can be both prevented and reversed by gene therapy using micro-dystrophins.

Comment in

  • Shrinking genes for therapy.
    Bonetta L. Bonetta L. Nat Med. 2002 Mar;8(3):222. doi: 10.1038/nm0302-222. Nat Med. 2002. PMID: 11875490 No abstract available.

Similar articles

See all similar articles

Cited by 206 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback